6896 Golden Throat Holdings Group Co Ltd
Golden Throat Holdings Group Co (6896) news
Golden Throat Holdings Group Co Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 6896, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Golden Throat Holdings Group Co news
We have not published a story on Golden Throat Holdings Group Co yet. When there is news, it will appear here.
Questions about Golden Throat Holdings Group Co
What is the ticker symbol of Golden Throat Holdings Group Co?
Golden Throat Holdings Group Co Ltd trades under the ticker 6896 on HKEX.
Where is Golden Throat Holdings Group Co listed?
Golden Throat Holdings Group Co Ltd is listed on HKEX.
Which country or territory is Golden Throat Holdings Group Co listed under?
Our directory records Golden Throat Holdings Group Co Ltd under China.
What does Golden Throat Holdings Group Co do?
Our directory classifies Golden Throat Holdings Group Co Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Golden Throat Holdings Group Co?
The ISIN recorded for Golden Throat Holdings Group Co Ltd is KYG3961J1022.
Does aibio.space cover Golden Throat Holdings Group Co?
aibio.space lists Golden Throat Holdings Group Co Ltd among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to Golden Throat Holdings Group Co?
Companies in our directory listed in the same country and business area as Golden Throat Holdings Group Co: Beijing TongRenTang Co., Shandong Wit Dyne Health Co., Jiangxi Synergy Pharmaceutical Co., Lepu Biopharma Co., Fusen Pharmaceutical Co., Jiangsu Jibeier Pharmaceutical Co..
Investor discussion: Golden Throat Holdings Group Co
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES (INCLUDING SALE OR TRANSFER OF TREASURY SHARES) AND REPURCHASE SHARES DECLARATION OF FINAL DIVIDEND RE-APPOINTMENT OF AUDITOR PROPOSED AMENDMENTS TO EXISTING ARTICLES OF ASSOCIATION AND ADOPTION OF NEW ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING. Source
- Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES (INCLUDING SALE OR TRANSFER OF TREASURY SHARES) AND REPURCHASE SHARES DECLARATION OF FINAL DIVIDEND RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source
Press releases
- HKEXnews
- HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
- HKEXnews
- HKEXnews
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
- HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2026
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED)
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
- HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 3 JUNE 2025
- HKEXnews
- HKEXnews
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED)
- HKEXnews
- HKEXnews
- HKEXnews
Stock chart
Listing details
- Company
- Golden Throat Holdings Group Co Ltd
- Ticker
- 6896
- Listing
- HKEX
- Country or territory
- China
- Business scope
- Pharmaceuticals: Major
- ISIN
- KYG3961J1022
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio